FGF21 can protect animals from diet-induced obesity and reduce hepatic lipid accumulation, enhance glucose metabolism, and thus prevent hepatic steatosis, fibrosis, and NAFLD when administered to diabetic rodents8–10,12,15,16. The gene discussed is FGF21; the disease is Hepatic steatosis.